Silintan capsules, a nutritional supplement intended for joint and body pain, have been withdrawn from the market due to the presence of meloxicam. Meloxicam is a non-steroidal anti-inflammatory drug (NSAID). This supplement is linked to the risk of stroke. The cheese recall is marked as the most serious. A pioneer of GLP-1 drugs has died. The article is from MedPage Today and notes that some links may require registration or subscription.